Abstract
Purpose
Prostate cancer screening has not significantly reduced mortality. International guidelines strongly endorse shared decision-making to navigate risks, emphasizing its crucial role prior to prescribing a prostate-specific antigen test. This study aims to provide insight into the current role of shared decision-making in primary care for prostate cancer screening and suggest ways to improve the process.
Methods
PubMed, Cochrane, and Lissa databases were searched for following terms: ‘prostate-specific antigen’ or ‘prostate cancer screening’ combined with ‘shared decision making’, ‘informed decision making’ or ‘decision support’ and ‘primary care’. All studies were screened by two independent reviewers. This systematic review followed the PRISMA guidelines.
Results
Of 85 articles screened, 34 were included. Key findings included heterogenous and poor quality implementation of shared decision-making in practice, patients with limited knowledge of shared decision-making, clinicians infrequently discussing patients’ views, decision aids that could be better integrated into practice, and finally, changes in care systems to support the expansion of shared decision-making in prostate cancer screening.
Conclusion
Decision aids are essential tools in the informed decision-making process. Integrating these elements into practice would require training for doctors and adjustments to the healthcare system.
Similar content being viewed by others
References
SPF Estimations nationales de l’incidence et de la mortalité par cancer en France métropolitaine entre 1990 et 2018—Tumeurs solides: Étude à partir des registres des cancers du réseau Francim. https://www.santepubliquefrance.fr/import/estimations-nationales-de-l-incidence-et-de-la-mortalite-par-cancer-en-france-metropolitaine-entre-1990-et-2018-tumeurs-solides-etude-a-partir. Accessed 17 Sep 2023
Martin RM, Donovan JL, Turner EL et al (2018) Effect of a low-intensity PSA-based screening intervention on prostate cancer mortality: the CAP randomized clinical trial. JAMA 319:883–895. https://doi.org/10.1001/jama.2018.0154
Andriole GL, Crawford ED, Grubb RL et al (2009) Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360:1310–1319. https://doi.org/10.1056/NEJMoa0810696
Charvin M, Moutel G, Launoy G, Berchi C (2022) Perceptions et connaissances concernant la décision de réaliser le dépistage du cancer de la prostate. Santé Publique 34:107–118. https://doi.org/10.3917/spub.221.0107
Cancer CCS/S canadienne du Test de l’antigène prostatique spécifique (APS). In: Société Can. Cancer. https://cancer.ca/fr/treatments/tests-and-procedures/prostate-specific-antigen-psa-test. Accessed 7 Nov 2023
Taylor KL, Luta G, Hoffman RM et al (2018) Quality of life among men with low-risk prostate cancer during the first year following diagnosis: the PREPARE prospective cohort study. Transl Behav Med 8:156–165. https://doi.org/10.1093/tbm/ibx005
Srivastava S, Koay EJ, Borowsky AD et al (2019) Cancer overdiagnosis: a biological challenge and clinical dilemma. Nat Rev Cancer 19:349–358. https://doi.org/10.1038/s41568-019-0142-8
US Preventive Services Task Force, Grossman DC, Curry SJ et al (2018) Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 319:1901. https://doi.org/10.1001/jama.2018.3710
Implementation of Shared Decision Making into Urological Practice—American Urological Association. https://www.auanet.org/guidelines-and-quality/quality-and-measurement/quality-improvement/clinical-consensus-statement-and-quality-improvement-issue-brief-(ccs-and-qiib)/shared-decision-making. Accessed 3 Dec 2023
Rapport d’orientation—Cancer de la prostate
Selby K, Auer R, Valerio M et al (2015) Dépistage du cancer de la prostate: partager avec le patient les incertitudes. Rev Med Suisse 496:2216–2220
Gedda M (2015) Traduction française des lignes directrices PRISMA pour l’écriture et la lecture des revues systématiques et des méta-analyses. Kinésithérapie Rev 15:39–44. https://doi.org/10.1016/j.kine.2014.11.004
Methley AM, Campbell S, Chew-Graham C et al (2014) PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews. BMC Health Serv Res 14:579. https://doi.org/10.1186/s12913-014-0579-0
Thomas J, Harden A (2008) Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med Res Methodol 8:45. https://doi.org/10.1186/1471-2288-8-45
Martínez-González NA, Plate A, Senn O et al (2018) Shared decision-making for prostate cancer screening and treatment: a systematic review of randomised controlled trials. Swiss Med Wkly 148:w14584. https://doi.org/10.4414/smw.2018.14584
Feng B, Srinivasan M, Hoffman JR et al (2013) Physician communication regarding prostate cancer screening: analysis of unannounced standardized patient visits. Ann Fam Med 11:315–323. https://doi.org/10.1370/afm.1509
Leader A, Daskalakis C, Braddock CH et al (2012) Measuring informed decision making about prostate cancer screening in primary care. Med Decis Mak Int J Soc Med Decis Mak 32:327–336. https://doi.org/10.1177/0272989X11410064
Maffei RM (2012) Developing a conceptual map of patient information needs in prostate cancer screening. NI 2012 2012:273
Elwyn G, Frosch D, Thomson R et al (2012) Shared decision making: a model for clinical practice. J Gen Intern Med 27:1361–1367. https://doi.org/10.1007/s11606-012-2077-6
Ragsdale JW, Halstater B, Martinez-Bianchi V (2014) Prostate cancer screening. Prim Care 41:355–370. https://doi.org/10.1016/j.pop.2014.02.009
Kuss K, Adarkwah CC, Becker M et al (2021) Delivering the unexpected-Information needs for PSA screening from Men’s perspective: a qualitative study. Health Expect Int J Public Particip Health Care Health Policy 24:1403–1412. https://doi.org/10.1111/hex.13275
Carlsson SV, Vickers AJ (2020) Screening for prostate cancer. Med Clin North Am 104:1051–1062. https://doi.org/10.1016/j.mcna.2020.08.007
Martínez-González NA, Neuner-Jehle S, Plate A et al (2018) The effects of shared decision-making compared to usual care for prostate cancer screening decisions: a systematic review and meta-analysis. BMC Cancer 18:1015. https://doi.org/10.1186/s12885-018-4794-7
Wilkes MS, Day FC, Srinivasan M et al (2013) Pairing physician education with patient activation to improve shared decisions in prostate cancer screening: a cluster randomized controlled trial. Ann Fam Med 11:324–334. https://doi.org/10.1370/afm.1550
Bowen DJ, Hannon PA, Harris JR, Martin DP (2011) Prostate cancer screening and informed decision-making: provider and patient perspectives. Prostate Cancer Prostatic Dis 14:155–161. https://doi.org/10.1038/pcan.2010.55
Ross LE, Hall IJ, Howard DL et al (2018) Primary care physicians beliefs about prostate-specific antigen evidence uncertainty, screening efficacy, and test use. J Natl Med Assoc 110:491–500. https://doi.org/10.1016/j.jnma.2017.12.007
Sebo P, Maisonneuve H, Cerutti B et al (2017) Overview of preventive practices provided by primary care physicians: a cross-sectional study in Switzerland and France. PLoS ONE 12:e0184032. https://doi.org/10.1371/journal.pone.0184032
Volk RJ, Linder SK, Kallen MA et al (2013) Primary care physicians’ use of an informed decision-making process for prostate cancer screening. Ann Fam Med 11:67–74. https://doi.org/10.1370/afm.1445
Davis K, Haisfield L, Dorfman C et al (2011) Physicians’ attitudes about shared decision making for prostate cancer screening. Fam Med 43:260–266
Myers RE, Daskalakis C, Kunkel EJS et al (2011) Mediated decision support in prostate cancer screening: a randomized controlled trial of decision counseling. Patient Educ Couns 83:240–246. https://doi.org/10.1016/j.pec.2010.06.011
Rim SH, Hall IJ, Massetti GM et al (2019) Primary care providers’ intended use of decision aids for prostate-specific antigen testing for prostate cancer screening. J Cancer Educ 34:666–670. https://doi.org/10.1007/s13187-018-1353-5
Shungu N, Sterba KR (2021) Barriers and facilitators to informed decision-making about prostate cancer screening among Black men. J Am Board Fam Med 34:925–936. https://doi.org/10.3122/jabfm.2021.05.210149
Rezaee ME, Ward CE, Sverrisson EF, Dagrosa LM (2019) Brief report: impact of healthcare quality on prostate specific antigen screening for the early detection of prostate cancer. Prev Med Rep 14:100838. https://doi.org/10.1016/j.pmedr.2019.100838
Tran V-T, Kisseleva-Romanova E, Rigal L, Falcoff H (2015) Impact of a printed decision aid on patients’ intention to undergo prostate cancer screening: a multicentre, pragmatic randomised controlled trial in primary care. Br J Gen Pract J R Coll Gen Pract 65:e295-304. https://doi.org/10.3399/bjgp15X684817
Liao JM, Ommerborn MJ, Clark CR (2017) Association between features of patient-provider discussions and routine prostate-specific antigen testing. PLoS ONE 12:e0177687. https://doi.org/10.1371/journal.pone.0177687
Taylor KL, Williams RM, Davis K et al (2013) Decision making in prostate cancer screening using decision aids vs usual care: a randomized clinical trial. JAMA Intern Med 173:1704–1712. https://doi.org/10.1001/jamainternmed.2013.9253
Stacey D, Légaré F, Lewis K et al (2017) Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 4(4):CD001431. https://doi.org/10.1002/14651858.CD001431.pub5
Tomko C, Davis KM, Luta G et al (2015) A comparison of web-based versus print-based decision AIDS for prostate cancer screening: participants’ evaluation and utilization. J Gen Intern Med 30:33–42. https://doi.org/10.1007/s11606-014-2994-7
Allen JD, Filson CP, Berry DL (2020) Effect of a prostate cancer screening decision aid for African-American men in primary care settings. Cancer Epidemiol Biomark Prev 29:2157–2164. https://doi.org/10.1158/1055-9965.EPI-20-0454
Evans R, Joseph-Williams N, Edwards A et al (2010) Supporting informed decision making for prostate specific antigen (PSA) testing on the web: an online randomized controlled trial. J Med Internet Res 12:e27. https://doi.org/10.2196/jmir.1305
Day FC, Pourhomayoun M, Keeves D et al (2019) Feasibility study of an EHR-integrated mobile shared decision making application. Int J Med Inf 124:24–30. https://doi.org/10.1016/j.ijmedinf.2019.01.008
Cunich M, Salkeld G, Dowie J et al (2011) Integrating evidence and individual preferences using a web-based multi-criteria decision analytic tool: an application to prostate cancer screening. Patient 4:153–162. https://doi.org/10.2165/11587070-000000000-00000
Joseph-Williams N, Evans R, Edwards A et al (2010) Supporting informed decision making online in 20 minutes: an observational web-log study of a PSA test decision aid. J Med Internet Res 12:e15. https://doi.org/10.2196/jmir.1307
Warlick CA, Berge JM, Ho Y-Y, Yeazel M (2017) Impact of a prostate specific antigen screening decision aid on clinic function. Urol Pract 4:448–453. https://doi.org/10.1016/j.urpr.2016.11.004
Pickles K, Kazda L, Barratt A et al (2020) Evaluating two decision aids for Australian men supporting informed decisions about prostate cancer screening: a randomised controlled trial. PLoS ONE 15:e0227304. https://doi.org/10.1371/journal.pone.0227304
Barry MJ, Wexler RM, Brackett CD et al (2015) Responses to a decision aid on prostate cancer screening in primary care practices. Am J Prev Med 49:520–525. https://doi.org/10.1016/j.amepre.2015.03.002
Stamm AW, Banerji JS, Wolff EM et al (2017) A decision aid versus shared decision making for prostate cancer screening: results of a randomized, controlled trial. Can J Urol 24:8910–8917
Lewis CL, Adams J, Tai-Seale M et al (2015) A randomized controlled effectiveness trial for PSA screening decision support interventions in two primary care settings. J Gen Intern Med 30:810–816. https://doi.org/10.1007/s11606-015-3214-9
Allen JD, Porteny T, Kaplan A et al (2022) Does shared decision-making for prostate cancer screening among African American men happen? It depends on who you ask. J Racial Ethn Health Disparities 9:1225–1233. https://doi.org/10.1007/s40615-021-01064-x
Wilkes M, Srinivasan M, Cole G et al (2013) Discussing uncertainty and risk in primary care: recommendations of a multi-disciplinary panel regarding communication around prostate cancer screening. J Gen Intern Med 28:1410–1419. https://doi.org/10.1007/s11606-013-2419-z
Davis DA, Thomson MA, Oxman AD, Haynes RB (1995) Changing physician performance. A systematic review of the effect of continuing medical education strategies. JAMA 274:700–705. https://doi.org/10.1001/jama.274.9.700
Cantillon P, Jones R (1999) Does continuing medical education in general practice make a difference? BMJ 318:1276–1279. https://doi.org/10.1136/bmj.318.7193.1276
Pearson WS, King DE, Richards C (2013) Capitated payments to primary care providers and the delivery of patient education. J Am Board Fam Med JABFM 26:350–355. https://doi.org/10.3122/jabfm.2013.04.120301
Otiono K, Nkonge B, Olaiya OR, Pierre S (2023) Dépistage du cancer de la prostate chez les hommes noirs au Canada: Argument en faveur des soins stratifiés en fonction du risque. CMAJ Can Med Assoc J 195:E101–E105. https://doi.org/10.1503/cmaj.220452-f
Acknowledgements
The authors would like to express their gratitude to the department of general practice of Aix-Marseille University for his support.
Author information
Authors and Affiliations
Contributions
Conceptualization, RL and TF ; Methodology, RL and TF ; Formal Analysis, RL and QO; Review Investigation, RL and QO; Writing—Original Draft Preparation, RL and QO and TF; Writing—Review and Editing, RL and QO; Visualization, RL and QO; Supervision, TF
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Lutaud, R., Ollivier, Q. & Fierling, T. Shared medical decision in prostate cancer screening in primary care: a systematic literature review of current evidence. Int Urol Nephrol (2024). https://doi.org/10.1007/s11255-024-03947-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11255-024-03947-4